Batawi, Hannan .

HRN: 24-37-84  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/08/2024
CEFUROXIME 1.5GM (VIAL)
01/08/2024
01/14/2024
IVT
150 Mg
Q8
Pcap C
Waiting Final Action 
01/08/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/08/2024
01/14/2024
IVT
75 Mg
Q8
Pcap C, PBO
Waiting Final Action 
01/12/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
01/12/2024
01/18/2024
PO
2ml
TID
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: